GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » COGS-to-Revenue

China Medical System Holdings (HKSE:00867) COGS-to-Revenue : 0.26 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings COGS-to-Revenue?

China Medical System Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$984 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$3,722 Mil.

China Medical System Holdings's COGS to Revenue for the six months ended in Dec. 2023 was 0.26.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. China Medical System Holdings's Gross Margin % for the six months ended in Dec. 2023 was 73.56%.

China Medical System Holdings COGS-to-Revenue Historical Data

The historical data trend for China Medical System Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings COGS-to-Revenue Chart

China Medical System Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.26 0.25 0.23 0.24

China Medical System Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.23 0.23 0.22 0.26

China Medical System Holdings COGS-to-Revenue Calculation

China Medical System Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2082.685 / 8764.762
=0.24

China Medical System Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=984.272 / 3722.302
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Medical System Holdings  (HKSE:00867) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

China Medical System Holdings's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 984.272 / 3722.302
=73.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

China Medical System Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

China Medical System Holdings (HKSE:00867) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:03320 HKSE:00570 HKSE:02096 HKSE:02005 HKSE:00512 HKSE:03933 HKSE:06185 HKSE:03613 HKSE:06600 HKSE:01558 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
2M7C:Germany
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
Website
http://www.cms.net.cn
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.
Executives
Treasure Sea Limited 2101 Beneficial owner
Lam Kong 2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines